Approach to dealing with acute heart failure in cats and dogs
In Pract. June 2023;45(5):252-266. 7 Refs
Melanie Hezzell1 1 University of Cambridge, The Old Schools, Trinity Ln, Cambridge CB2 1TN, United Kingdom.
Author Abstract
Background: Unfortunately, heart disease is common in both dogs and cats and may eventually result in congestive heart failure (CHF). However, the clinical signs of CHF overlap with other causes of respiratory compromise. As such, differentiating cardiac from non-cardiac causes of respiratory distress is a common diagnostic challenge in emergency veterinary practice. The general principles of heart failure management can be applied to a broad range of cardiac diseases; identifying a cardiac cause for the clinical signs is therefore more important than making a definitive diagnosis in the acute phase of heart failure. Nevertheless, there is no ‘one-size-fits-all’ recipe for treatment and the approach needs to be tailored to the individual (eg, severity of clinical signs, comorbidities, patient demeanour and so on). Although the information in this article is organised linearly, the approach to an emergency case seldom follows the structure used in more stable patients. For example, a dog or cat presenting with significant dyspnoea will typically require treatment (eg, supplementary oxygen ± light sedation) before physical examination and diagnostic testing, and some diagnostic tests may need to be postponed until the patient is stable enough to safely undergo them; therefore, the initial treatment plan is often based on a working, rather than a definitive, diagnosis.
Aim of the article: This article provides an overview of the diagnosis and management of acute heart failure, highlighting similarities and differences between dogs and cats. The aim is to help practitioners approach these cases with more confidence.
|
 |
Article Tools:
Archives Highlights:
Effects of intranasal maropitant on clinical signs of naturally acquired upper respiratory disease in shelter cats.
There was no significant difference in clinical improvement score between the maropitant treatment and control groups for conjunctivitis, blepharospasm, ocular discharge, nasal discharge, or total disease severity after 7 days.
|
Duration of efficacy and effect of implant location in adult queens treated with a 9.4 mg deslorelin subcutaneous implant.
The average duration of action of the 9.4 mg deslorelin implant was 790 ± 155 days (range 525-1140 days) with no significant difference in duration or efficacy depending on implantation sites. The 9.4 mg deslorelin implant causes pharmacological sterilization for about 2 years in female cats, is fully reversible, and caused no clinically relevant side effects when administered at both interscapular and periumbilical sites.
|
Use of Dog Serologic Data for Improved Understanding of Coccidioidomycosis: A One Health Approach.
The overall seropositivity rate among tested dogs was 37.6%. Average test positivity rates in states with =0.5 tests per annum per 10,000 households were 35.4% (Texas) to 74.1% (Montana). For these states, average annual incidence per 10,000 households was as follows: Arizona (86.8), New Mexico (0.89), Nevada (0.78), California (0.75), Montana (0.63), Colorado (0.41), Oregon (0.41), Texas (0.38), Idaho (0.37), Wyoming (0.34), Utah (0.32), and Washington (0.26). Human incidence in California and Arizona between 2012 and 2022 was significantly correlated with dog incidence.
|
Endoparasites of rabbits and hares.
Accurate gross and microscopic identification of endoparasites in rabbits and hares is an important element of the diagnostic work of veterinary anatomic pathologists. Given the zoonotic nature of rabbit and hare endoparasites, such as C. hepatica, E. cuniculi, and others, veterinary pathologists are ideally poised to make valuable contributions to the understanding of the disease ecology of these pathogens in the context of a One Health research program.
|
Prevalence of discospondylitis and association with congenital vertebral body malformations in English and French bulldogs.
The prevalence of discospondylitis was 3.4 (1.6-6.7) times higher in French bulldogs and 4.3 (1.7-9.8) times higher in English bulldogs, compared with the overall hospital cohort. One or more vertebral malformations were present in 12 French bulldogs (92.3%), 6 English bulldogs (75.0%), and 1 "other" breed dog (1.1%). Discospondylitis was diagnosed adjacent to congenital vertebral body malformations in 12 (80%) intervertebral discs in French bulldogs and 5 (50%) intervertebral discs in English bulldogs.
|
|